# SAGABIO

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/sagabio

- Industry: Biotechnology
- Headquarters: Shanghai, China
- Website: www.sagabio.cn
- Latest round: Series A (Oct 21, 2019)
- Investors on record: 1

## About

Based in Shanghai, SAGABIO is a biotechnology company that engages in the R&D, and production, and sales of biological detection devices. It adopts the business model of instrument reagent linkage sales, which free-charge provides instruments to physical examination institutions, and hospitals, and sells the consumables regents.   It established cooperation with the physical examination institution, Messinian Health. 

Its products include near-infrared fluorescent labeling chips, silica gel matrix membranes as protein chips, and biochip scanners. It adopts the silica gel matrix membrane as protein chips, which form multi-channel reaction sample holes, simplifying the chip reaction cleaning process, improving the detection sensitivity, and short the reaction times. The biochip scanners adopt point-by-point and line-by-line scanning, with high image resolution and no distortion.

## Funding rounds

- Series A, Oct 21, 2019 — China Summit Capital

## Investors

- China Summit Capital (https://capitalatlas.ai/funds/china-summit-capital) — Series A